Skip to main content

Articles

Page 72 of 335

  1. Cancer stem cells (CSCs) are implicated in carcinogenesis, cancer progression, and recurrence. Several biomarkers have been described for pancreatic ductal adenocarcinoma (PDAC) CSCs; however, their function a...

    Authors: Jung Hyun Jo, Sun A Kim, Jeong Hoon Lee, Yu Rang Park, Chanyang Kim, Soo Been Park, Dawoon E. Jung, Hee Seung Lee, Moon Jae Chung and Si Young Song
    Citation: BMC Cancer 2021 21:1241
  2. Malignant pleural mesothelioma (MPM) is a rare and aggressive carcinoma located in pleural cavity. Due to lack of effective diagnostic biomarkers and therapeutic targets in MPM, the prognosis is extremely poor...

    Authors: Zhongjian Chen, Chenxi Yang, Zhenying Guo, Siyu Song, Yun Gao, Ding Wang, Weimin Mao and Junping Liu
    Citation: BMC Cancer 2021 21:1235
  3. β-lapachone (β-lap), the NQO1 bioactivatable drug, is thought to be a promising anticancer agent. However, the toxic side effects of β-lap limit the drug use, highlighting the need for a thorough understanding...

    Authors: Yansong Zheng, Hengce Zhang, Yueting Guo, Yuan Chen, Hanglong Chen and Yingchun Liu
    Citation: BMC Cancer 2021 21:1234
  4. RNA editing leads to post-transcriptional variation in protein sequences and has important biological implications. We sought to elucidate the landscape of RNA editing events across pediatric cancers.

    Authors: Ji Wen, Michael Rusch, Samuel W. Brady, Ying Shao, Michael N. Edmonson, Timothy I. Shaw, Brent B. Powers, Liqing Tian, John Easton, Charles G. Mullighan, Tanja Gruber, David Ellison and Jinghui Zhang
    Citation: BMC Cancer 2021 21:1233
  5. To reduce disease recurrence after radical surgery for lung squamous cell carcinomas (SQCCs), accurate prediction of recurrent high-risk patients is required for efficient patient selection for adjuvant chemot...

    Authors: Yusuke Takanashi, Kazuhito Funai, Fumihiro Eto, Kiyomichi Mizuno, Akikazu Kawase, Hong Tao, Takuya Kitamoto, Yutaka Takahashi, Haruhiko Sugimura, Mitsutoshi Setou, Tomoaki Kahyo and Norihiko Shiiya
    Citation: BMC Cancer 2021 21:1232
  6. The correlation between tumor location and lymphatic flow distribution in gastric cancer has been previously reported, and PTD (Proximal – Transitional – Distal) classification was proposed. Our group updated ...

    Authors: Shinichi Kinami, Naohiko Nakamura, Tomoharu Miyashita, Hidekazu Kitakata, Sachio Fushida, Takashi Fujimura, Tohru Itoh and Hiroyuki Takamura
    Citation: BMC Cancer 2021 21:1231
  7. Cervical carcinoma is one of the most common malignant tumors of the female reproductive system. Lymph nodes metastasis, the most common metastasis, which can be detected even in small-size tumor patients, res...

    Authors: Ping Yang, Youqin Ruan, Zhiling Yan, Yang Gao, Hongying Yang and Shaojia Wang
    Citation: BMC Cancer 2021 21:1230
  8. The optimal modality for postoperative analgesia after uniportal video-assisted thoracoscopic surgery (UVATS) for the treatment of lung cancer has not yet been determined. Both ultrasound-guided paravertebral ...

    Authors: Qiang Wang, Shijing Wei, Shuai Li, Jie Yu, Guohua Zhang, Cheng Ni, Li Sun and Hui Zheng
    Citation: BMC Cancer 2021 21:1229
  9. Nomograms are rarely employed to estimate the survival of patients with advanced and metastatic pancreatic cancer (PC). Herein, we developed a comprehensive approach to using a nomogram to predict survival pro...

    Authors: G. C. Deng, Y. Lv, H. Yan, D. C. Sun, T. T. Qu, Y. T. Pan, Q. L. Han and G. H. Dai
    Citation: BMC Cancer 2021 21:1227
  10. Pancreatic ductal adenocarcinoma (PDAC) is a highly lethal disease with rising incidence and with 5-years overall survival of less than 8%. PDAC creates an immune-suppressive tumor microenvironment to escape i...

    Authors: Sajad Shafiekhani, Hojat Dehghanbanadaki, Azam Sadat Fatemi, Sara Rahbar, Jamshid Hadjati and Amir Homayoun Jafari
    Citation: BMC Cancer 2021 21:1226
  11. Limited treatment options exist for relapsed advanced lung squamous cell carcinoma (SCC), leading to poor outcomes compared with adenocarcinoma. This study aimed to investigate the efficacy of second-line afat...

    Authors: You-Yi Chen, Shih-Chieh Chang, Cheng-Yu Chang, Chun-Fu Chang, Yi-Chun Lai, Yu-Feng Wei and Chung-Yu Chen
    Citation: BMC Cancer 2021 21:1225
  12. CRBP-1, a cytosolic chaperone of vitamin A, is identified in a serious number of cancers; however, its biological role in hepatocellular carcinoma (HCC) needs to be further explored. The aim of our present stu...

    Authors: Xiangye Liu, Wenhua Shan, Tingting Li, Xiaoge Gao, Fanyun Kong, Hongjuan You, Delong Kong, Shuxi Qiao and Renxian Tang
    Citation: BMC Cancer 2021 21:1224
  13. To investigate risk factors for orally administered 5-aminolevulinic acid (ALA)-induced hypotension for bladder cancer patients receiving photodynamic diagnosis (PDD)-assisted transurethral resection of bladde...

    Authors: Hideo Fukuhara, Takahiro Nohara, Koshiro Nishimoto, Yutaka Hatakeyama, Yuki Hyodo, Yoshiyasu Okuhara, Masafumi Oyama, Atsushi Mizokami, Keiji Inoue and Hideyasu Matsuyama
    Citation: BMC Cancer 2021 21:1223
  14. Immune checkpoint blockade (ICB) therapies have changed the paradigm of cancer therapies. However, anti-tumor response of the ICB is insufficient for many patients and limited to specific tumor types. Despite ...

    Authors: Yosuke Sato, Yu Fu, Hong Liu, Min Young Lee and Michael H. Shaw
    Citation: BMC Cancer 2021 21:1222
  15. The predictive role of blood-based tumor mutation burden (bTMB) for selecting advanced nonsmall cell lung cancer (NSCLC) patients who might benefit from immune checkpoint inhibitors (ICIs) is still under debat...

    Authors: He Ba, Lei Liu, Qiang Peng, Jie Chen and Yao-dong Zhu
    Citation: BMC Cancer 2021 21:1220
  16. The mortality rate of patients with unresectable gastric cancer (UGC) has decreased with the development of chemotherapies and surgical techniques. However, the survival rate remains low. We retrospectively ex...

    Authors: Tomoyuki Matsunaga, Hiroaki Saito, Wataru Miyauchi, Yuji Shishido, Kozo Miyatani, Masaki Morimoto, Yuki Murakami, Takehiko Hanaki, Kyoichi Kihara, Manabu Yamamoto, Naruo Tokuyasu, Shuichi Takano, Teruhisa Sakamoto, Toshimichi Hasegawa and Yoshiyuki Fujiwara
    Citation: BMC Cancer 2021 21:1219
  17. MicroRNAs (miRNAs) have been reported to play significant roles in non-small-cell lung cancer (NSCLC). However, the roles of microRNA (miR)-1915-3p in NSCLC remain unclear. In this study, we aimed to explore t...

    Authors: Hongli Pan, Zhenhua Pan, Fengjie Guo, Fanrong Meng, Lingling Zu, Yaguang Fan, Yang Li, Mengjie Li, Xinxin Du, Xiuwen Zhang, Yi Shao, Mingming Wei, Xuebing Li and Qinghua Zhou
    Citation: BMC Cancer 2021 21:1218
  18. Melanoma incidence has quadrupled since 1970 and melanoma is now the second most common cancer in individuals under 50. Targeted immunotherapies for melanoma now potentially enable long-term remission even in ...

    Authors: Felicity Reilly, Lynda Contstable, William Brant, Kaz Rahman, Amer Durrani, Nigel Burrows, Charlotte Proby, Julia Allan, Marie Johnston, Derek Johnston, Fiona Walter and Peter Murchie
    Citation: BMC Cancer 2021 21:1217
  19. Studies have shown that the Sec61 gamma subunit (SEC61G) is overexpressed in several tumors and could serve as a potential prognostic marker. However, the correlation between SEC61G and lung adenocarcinoma (LU...

    Authors: Qunhao Zheng, Zhiping Wang, Mengyan Zhang, Yilin Yu, Rui Chen, Tianzhu Lu, Lingyun Liu, Jiayu Ma, Tianxiu Liu, Hongying Zheng, Hui Li and Jiancheng Li
    Citation: BMC Cancer 2021 21:1216
  20. In the existing next generation sequencing (NGS) system, epidermal growth factor receptor (EGFR) exon 19 deletion-insertion (19delins) is still interpreted into the category of EGFR exon 19 deletion (19del). H...

    Authors: Yurong Wang, Ruipan Zheng, Peizhu Hu, Ziheng Zhang, Shujing Shen and Xingya Li
    Citation: BMC Cancer 2021 21:1215
  21. Neoadjuvant therapy can lead to different tumor regression grades (TRG) in rectal cancer after neoadjuvant therapy. The purposes of this study are to investigate the relationships among TRG, pathologic complet...

    Authors: Jia-yi Li, Xuan-zhang Huang, Peng Gao, Yong-xi Song, Xiao-wan Chen, Xing-er Lv, Yv Fu, Qiong Xiao, Shi-yv Ye and Zhen-ning Wang
    Citation: BMC Cancer 2021 21:1214
  22. Despite of the frequently reported Dnmt3a abormality in classical myeloproliferative neoplasms (cMPNs) patients, few research explores how the Dnmt3a is regulated by Jak2V617F mutation. In this study, we have inv...

    Authors: Jie Zhou, Cheng Guo, Hao Wu, Bing Li, Li-Li Zhou, Ai-Bin Liang and Jian-Fei Fu
    Citation: BMC Cancer 2021 21:1213
  23. There is a growing level of interest in the potential role inflammation has on the initiation and progression of malignancy. Notable examples include Helicobacter pylori-mediated inflammation in gastric cancer an...

    Authors: Emily McIlvanna, Gerard J. Linden, Stephanie G. Craig, Fionnuala T. Lundy and Jacqueline A. James
    Citation: BMC Cancer 2021 21:1212
  24. Pancreatic adenocarcinoma (PAAD) is characterized by low antitumour immune cell infiltration in an immunosuppressive microenvironment. This study aimed to systematically explore the impact on prognostic altern...

    Authors: Bo Chen, Tuo Deng, Liming Deng, Haitao Yu, Bangjie He, Kaiyu Chen, Chongming Zheng, Daojie Wang, Yi Wang and Gang Chen
    Citation: BMC Cancer 2021 21:1211
  25. With the increasing number of breast cancer (BC) diagnosed as a second primary malignancy after a first primary non-breast cancer (BCa-2), it is unclear about the familial risk of BC among women with a first-d...

    Authors: Guoqiao Zheng, Jan Sundquist, Kristina Sundquist and Jianguang Ji
    Citation: BMC Cancer 2021 21:1210
  26. Daratumumab, a CD38 monoclonal antibody, has demonstrated efficacy as monotherapy and combination therapy across several indications, both among newly-diagnosed and refractory patients with multiple myeloma (M...

    Authors: Shebli ATRASH, Philippe THOMPSON-LEDUC, Ming-Hui TAI, Shuchita KAILA, Kathleen GRAY, Isabelle GHELERTER, Marie-Hélène LAFEUILLE, Patrick LEFEBVRE and Adriana ROSSI
    Citation: BMC Cancer 2021 21:1207

    The Correction to this article has been published in BMC Cancer 2021 21:1291

  27. Cytotoxic chemotherapy combinations and targeted agents represent established treatment concepts in advanced pancreatic neuroendocrine tumors (PNETs). However, response rates, side effects and outcome data str...

    Authors: Sebastian Krug, Thomas Kegel, Thomas M. Gress, Anja Rinke, Leonidas Apostolidis, Henning Jann, Alexander König, Dieter Hörsch, Jörg Schrader, Thomas J. Ettrich, Michael Richter, Jörg Steighardt and Patrick Michl
    Citation: BMC Cancer 2021 21:1206
  28. Forkhead box D1, the core transcription factor member of FOX family, has gradually seen as a key cancerous regulatory. However, its expression and carcinogenicity in head and neck squamous cell carcinoma (HNSC...

    Authors: Jin Li, Tingyuan Yan, Xiang Wu, Xueping Ke, Xin Li, Yumin Zhu, Jianrong Yang and Zhongwu Li
    Citation: BMC Cancer 2021 21:1205
  29. Trastuzumab emtansine (T-DM1) is indicated as second-line treatment for human epidermal growth factor receptor 2 (HER2)-positive metastatic or unresectable locally advanced breast cancer, after progression on ...

    Authors: A. Migeotte, V. Dufour, A. van Maanen, M. Berliere, J. L. Canon, D. Taylor and F. P. Duhoux
    Citation: BMC Cancer 2021 21:1204
  30. Infiltrating immune and stromal cells are important components of the endometrial cancer (EC) microenvironment, which has a significant effect on the biological behavior of EC, suggesting that unique immune-re...

    Authors: Yichen Wang, Jingkai Zhang, Yijun Zhou, Zhiguang Li, Dekang Lv and Quentin Liu
    Citation: BMC Cancer 2021 21:1203
  31. There is a growing concern that the use of anti-hypertensives may be associated with an increased risk of cancer, but it remains uncertain for the association between anti-hypertensives and lung cancer risk, a...

    Authors: Jinhui Li, Amy S. M. Lam, Sarah T. Y. Yau, Karen K. L. Yiu and Kelvin K. F. Tsoi
    Citation: BMC Cancer 2021 21:1202
  32. Radiotherapy is routinely used to combat glioblastoma (GBM). However, the treatment efficacy is often limited by the radioresistance of GBM cells.

    Authors: Cholpon S. Djuzenova, Thomas Fischer, Astrid Katzer, Dmitri Sisario, Tessa Korsa, Gudrun Steussloff, Vladimir L. Sukhorukov and Michael Flentje
    Citation: BMC Cancer 2021 21:1201
  33. In the widespread adoption of chemotherapy, drug resistance has been the major obstacle to tumor elimination in cancer patients. Our aim was to explore the role of TGF-β in osteosarcoma-associated chemoresista...

    Authors: Yangbo Xu, Yafei Li, Xiaofan Chen, Feifan Xiang, Yong Deng, Zhong Li and Daiqing Wei
    Citation: BMC Cancer 2021 21:1200
  34. The Wnt receptors ROR1 and ROR2 are generating increased interest as cancer therapeutic targets but remain understudied in pancreatic ductal adenocarcinoma (PDAC). Compared to canonical Wnt/ β-catenin signalli...

    Authors: Dongli Liu, George Sharbeen, Phoebe Phillips and Caroline E. Ford
    Citation: BMC Cancer 2021 21:1199
  35. Both activated tumor-infiltrating lymphocytes (TILs) and immune-suppressive cells, such as regulatory T cells (Tregs), in the tumor microenvironment (TME) play an important role in the prognosis of patients wi...

    Authors: Sachie Kiryu, Zensho Ito, Machi Suka, Tsuuse Bito, Shin Kan, Kan Uchiyama, Masayuki Saruta, Taigo Hata, Yuki Takano, Shuichi Fujioka, Takeyuki Misawa, Takashi Yamauchi, Hiroyuki Yanagisawa, Nobuhiro Sato, Toshifumi Ohkusa, Haruo Sugiyama…
    Citation: BMC Cancer 2021 21:1197
  36. Aurora A kinase is a cell cycle regulator that is dysregulated in several different malignancies. Nevertheless, its regulatory mechanisms are still not fully understood. Here, we report that ubiquitin specific...

    Authors: Ke Shi, Jin Zhong Zhang, Liang Yang, Ning-Ning Li, Ying Yue, Xiu-Hong Du, Xiu-Zhi Zhang, Yu Cheng Lu and Dan Guo
    Citation: BMC Cancer 2021 21:1196
  37. Studies increasingly show that positive psychological constructs affect the mental health of cancer patients. However, most scales that measure hope, resilience, optimism and self-efficacy have been developed ...

    Authors: Chun Ying Cui, Yu Wang, Ying Zhang, Siqi Chen, Nan Jiang and Lie Wang
    Citation: BMC Cancer 2021 21:1194
  38. The relationship between the type of anesthesia and the survival outcomes of gastric cancer patients is uncertain. This study compared the overall outcome of gastric cancer patients after surgery with total in...

    Authors: Wei-Wei Wu, Wei-Han Zhang, Wei-Yi Zhang, Kai Liu, Xin-Zu Chen, Zong-Guang Zhou, Jin Liu, Tao Zhu and Jian-Kun Hu
    Citation: BMC Cancer 2021 21:1193
  39. Tumor regression grade (TRG) after neoadjuvant therapy is reportedly predictive of prognosis in esophageal cancer patients, as lack of a response to neoadjuvant therapy is associated with a poor prognosis. How...

    Authors: Yushi Nagaki, Satoru Motoyama, Yusuke Sato, Akiyuki Wakita, Hiromu Fujita, Yoshihiro Sasaki, Kazuhiro Imai and Yoshihiro Minamiya
    Citation: BMC Cancer 2021 21:1192
  40. Authors: Mustafa Erman, Bivas Biswas, Pongwut Danchaivijitr, Lingwu Chen, Yoke Fui Wong, Tarek Hashem, Chun Sen Lim, Bulent Karabulut, Hsiao-Jen Chung, Chandrasekhar Chikatapu, Sara Ingles, Khemaies Slimane and Ravindran Kanesvaran
    Citation: BMC Cancer 2021 21:1191

    The original article was published in BMC Cancer 2021 21:1021

  41. Children with acute lymphoblastic leukemia (ALL) undergoing chemotherapy experience a relatively high risk of infection. And the disturbance of gut microbiota is generally believed to impair intestinal barrier...

    Authors: Xiaoming Liu, Yao Zou, Yingchi Zhang, Lipeng Liu, Yongjuan Duan, Aoli Zhang, Xiaoyan Zhang, Ranran Zhang, Beibei Zhao, Xiaolan Li, Tong Wei, Hongrui He, Yu Gan, Kejian Wang and Xiaofan Zhu
    Citation: BMC Cancer 2021 21:1190
  42. Malignant pleural mesothelioma (MPM) is a rare but fatal cancer, which is largely caused by exposure to asbestos. Reliable information about the incidence of MPM prior the influence of asbestos is lacking. The...

    Authors: Kari Hemminki, Asta Försti, Tianhui Chen and Akseli Hemminki
    Citation: BMC Cancer 2021 21:1189
  43. In recent years, gene expression-based analysis has been used for disease biomarker discovery, providing ways for better diagnosis, leading to improvement of clinical treatment efficacy. This study aimed to ex...

    Authors: Ziming Wang, Siyuan Hu, Xinyang Li, Zhiwei Liu, Danyang Han, Yukun Wang, Limin Wei, Guangping Zhang and Xinshuai Wang
    Citation: BMC Cancer 2021 21:1188
  44. Virtually all metastatic patients with metastatic melanoma who progress after initial treatment with PD-1 or CTLA-4 directed antibodies will die of their disease. Salvage options are urgently needed. It is the...

    Authors: Wolfram Samlowski and Camille Adajar
    Citation: BMC Cancer 2021 21:1187

Featured videos

View featured videos from across the BMC-series journals